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Abstract
Increasing the intracellular Zn2+ concentration with zinc-ionophores like pyrithione (PT) can efficiently impair the replication
of a variety of RNA viruses, including poliovirus and influenza virus. For some viruses this effect has been attributed to
interference with viral polyprotein processing. In this study we demonstrate that the combination of Zn2+ and PT at low
concentrations (2 mM Zn2+ and 2 mM PT) inhibits the replication of SARS-coronavirus (SARS-CoV) and equine arteritis virus
(EAV) in cell culture. The RNA synthesis of these two distantly related nidoviruses is catalyzed by an RNA-dependent RNA
polymerase (RdRp), which is the core enzyme of their multiprotein replication and transcription complex (RTC). Using an
activity assay for RTCs isolated from cells infected with SARS-CoV or EAV—thus eliminating the need for PT to transport Zn2+
across the plasma membrane—we show that Zn2+ efficiently inhibits the RNA-synthesizing activity of the RTCs of both
viruses. Enzymatic studies using recombinant RdRps (SARS-CoV nsp12 and EAV nsp9) purified from E. coli subsequently
revealed that Zn2+ directly inhibited the in vitro activity of both nidovirus polymerases. More specifically, Zn2+ was found to
block the initiation step of EAV RNA synthesis, whereas in the case of the SARS-CoV RdRp elongation was inhibited and
template binding reduced. By chelating Zn2+ with MgEDTA, the inhibitory effect of the divalent cation could be reversed,
which provides a novel experimental tool for in vitro studies of the molecular details of nidovirus replication and
transcription.
Citation: te Velthuis AJW, van den Worm SHE, Sims AC, Baric RS, Snijder EJ, et al. (2010) Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro
and Zinc Ionophores Block the Replication of These Viruses in Cell Culture. PLoS Pathog 6(11): e1001176. doi:10.1371/journal.ppat.1001176
Editor: Raul Andino, University of California San Francisco, United States of America
Received May 17, 2010; Accepted October 1, 2010; Published November 4, 2010
Copyright:  2010 te Velthuis et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Netherlands Organization for Scientific Research (NWO) with grants from the Council for Chemical Sciences (NWO-CW
grant 700.55.002 and 700.57.301) and an NWO Toptalent grant (021.001.037). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: e.j.snijder@lumc.nl (ES); m.j.van_hemert@lumc.nl (MJvH)
Introduction
Zinc ions are involved in many different cellular processes and
have proven crucial for the proper folding and activity of various
cellular enzymes and transcription factors. Zn2+ is probably an
important cofactor for numerous viral proteins as well. Neverthe-
less, the intracellular concentration of free Zn2+ is maintained at a
relatively low level by metallothioneins, likely due to the fact that
Zn2+ can serve as intracellular second messenger and may trigger
apoptosis or a decrease in protein synthesis at elevated
concentrations [1,2,3]. Interestingly, in cell culture studies, high
Zn2+ concentrations and the addition of compounds that stimulate
cellular import of Zn2+, such as hinokitol (HK), pyrrolidine
dithiocarbamate (PDTC) and pyrithione (PT), were found to
inhibit the replication of various RNA viruses, including influenza
virus [4], respiratory syncytial virus [5] and several picornaviruses
[6,7,8,9,10,11]. Although these previous studies provided limited
mechanistic information, this suggests that intracellular Zn2+ levels
affect a common step in the replicative cycle of these viruses.
In cell culture, PT stimulates Zn2+ uptake within minutes and
inhibits RNA virus replication through a mechanism that has
only been studied in reasonable detail for picornaviruses [11,12].
In vitro studies with purified rhinovirus and poliovirus 3C proteases
revealed that protease activity was inhibited by Zn2+ [13,14],
which is in line with the inhibition of polyprotein processing by
zinc ions that was observed in cells infected with human rhinovirus
and coxsackievirus B3 [11]. The replication of segmented
negative-strand RNA viruses such as influenza virus, however,
does not depend on polyprotein processing and the effect of
PDTC-mediated Zn2+ import was therefore hypothesized to result
from inhibition of the viral RNA-dependent RNA polymerase
(RdRp) and cellular cofactors [4]. Moreover, an inhibitory effect of
Zn2+ on the activity of purified RdRps from rhinoviruses and
hepatitis C virus was noted, but not investigated in any detail
[15,16].
Details on the effect of zinc ions are currently largely unknown
for nidoviruses. This large group of positive-strand RNA (+RNA)
viruses includes major pathogens of humans and livestock, such as
severe acute respiratory syndrome coronavirus (SARS-CoV), other
human coronaviruses, the arteriviruses equine arteritis virus
(EAV), and porcine reproductive and respiratory syndrome virus
(PRRSV) [17,18]. The common ancestry of nidoviruses is reflected
in their similar genome organization and expression strategy, and
in the conservation of a number of key enzymatic functions in their
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large replicase polyproteins [19]. A hallmark of the corona- and
arterivirus replicative cycle is the transcription of a 59- and 39-
coterminal nested set of subgenomic (sg) mRNAs from which the
viral structural and accessory protein genes are expressed [20,21].
Analogous to picornaviruses [13,22], zinc ions were demon-
strated to inhibit certain proteolytic cleavages in the processing of
the coronavirus replicase polyproteins in infected cells and cell-free
systems [23,24]. In this study we report that the zinc-ionophore
pyrithione (PT) in combination with Zn2+ is a potent inhibitor of
the replication of SARS-coronavirus (SARS-CoV) and equine
arteritis virus (EAV) in cell culture. To assess whether - besides a
possible effect on proteolytic processing - nidovirus RTC subunits
and RNA synthesis are directly affected by Zn2+, we employed in
vitro systems for SARS-CoV and EAV RNA synthesis that are
based on membrane-associated RTCs isolated from infected cells
(from here on referred to as RTC assays) [25,26]. In addition, we
used in vitro recombinant RdRp assays to directly study the effect of
zinc ions on the RdRps of SARS-CoV and EAV [27,28].
Using these independent in vitro approaches, we were able to
demonstrate that Zn2+ directly impairs nidovirus RNA synthesis,
since it had a strong inhibitory effect in both RTC and RdRp
assays. Interestingly, the Zn2+-mediated inhibition could be
reversed through the addition of a Zn2+ chelator (MgEDTA).
We therefore applied this compound to stop and restart the in vitro
RNA-synthesizing activity at will. This convenient tool allowed us
to study various mechanistic aspects of arteri- and coronavirus
RNA synthesis in more detail. Additionally, the zinc-mediated
inhibition of nidovirus RNA synthesis described here may provide
an interesting basis to further explore the use of zinc-ionophores in
antiviral therapy.
Results
Zinc and pyrithione inhibit nidovirus replication in vivo
Zinc ions are involved in many different cellular processes, but
the concentration of free Zn2+ is maintained at a relatively low
level by metallothioneins [1]. Zn2+ and compounds that stimulate
import of Zn2+ into cells, such as PT, were previously found to
inhibit replication of several picornaviruses, including rhinovirus-
es, foot-and-mouth disease virus, coxsackievirus, and mengovirus
in cell culture [6,7,8,9,10,11]. To determine whether Zn2+ has a
similar effect on nidoviruses, we investigated the effect of PT and
Zn2+ on the replication of EAV and SARS-CoV in Vero-E6 cells,
using reporter viruses that express green fluorescent proteins
(GFP), i.e., EAV-GFP [29] and SARS-CoV-GFP [30]. EAV-GFP
encodes an N-terminal fusion of GFP to the viral nonstructural
protein 2 (nsp2), one of the cleavage products of the replicase
polyproteins, and thus provides a direct readout for translation of
the replicase gene. In SARS-CoV-GFP, reporter expression occurs
from sg mRNA 7, following the replacement of two accessory
protein-coding genes (ORFs 7a and 7b) that are dispensable for
replication in cell culture.
We first assessed the cytotoxicity of a range of PT concentrations
(0–32 mM) in the presence of 0 to 8 mMZnOAc2. Treatment with PT
of concentrations up to 32 mM in combination with,4 mMZnOAc2
did not reduce the viability of mock-infected cells after 18 h (Fig. 1A),
as measured by the colorimetric MTS (3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) viabili-
ty assay. As elevated Zn2+ concentrations are known to inhibit cellular
translation, we also used metabolic labeling with 35S-methionine to
assess the effect of PT and Zn2+ on cellular protein synthesis.
Incubation of Vero-E6 cells for 18 h with the combinations of PT and
Zn2+ mentioned above, followed by a 2-h metabolic labeling,
revealed no change in overall cellular protein synthesis when the
concentration of ZnOAc2 was ,4 mM (data not shown).
Using these non-cytotoxic conditions we subsequently tested the
effect of PT and ZnOAc2 on EAV-GFP and SARS-CoV-GFP
replication. To this end, Vero-E6 cells in 96-well plates were
infected with a multiplicity of infection (m.o.i.) of 4. One hour post
infection (h p.i.), between 0 and 32 mM of PT and 0, 1, or 2 mM
ZnOAc2 were added to the culture medium. At 17 h p.i., a time
point at which GFP expression in untreated infected cells reaches
its maximum for both viruses, cells were fixed, and GFP
fluorescence was quantified.
The reporter gene expression of both SARS-CoV-GFP and
EAV-GFP was already significantly inhibited in a dose-dependent
manner by the addition of PT alone (Fig. 1B and C). This effect
was significantly enhanced when 2 mM of Zn2+ was added to the
medium. We found that addition of ZnOAc2 alone also reduced
virus replication, but only at levels that were close to the 50%
cytotoxicity concentration (CC50) of ZnOAc2 in Vero-E6 cells
(,70 mM, data not shown). This is likely due to the poor solubility
of Zn2+ in phosphate-containing medium and the inefficient
uptake of Zn2+ by cells in the absence of zinc-ionophores. The
combination of 2 mM PT and 2 mM ZnOAc2 resulted in a 9861%
and 8563% reduction of the GFP signal for EAV-GFP and
SARS-CoV-GFP, respectively. No cytotoxicity was observed for
this combination of PT and ZnOAc2 concentrations. From the
dose-response curves in Fig. 1, a CC50 value of 82 mM was
calculated for PT in the presence of 2 mM zinc. Half maximal
inhibitory concentrations (IC50) of 1.4 mM and 0.5 mM and
selectivity indices of 59 and 164 were calculated for SARS-CoV
and EAV, respectively.
Zn2+ reversibly inhibits the RNA-synthesizing activity of
isolated nidovirus RTCs
We previously developed assays to study the in vitro RNA-
synthesizing activity of RTCs isolated from cells infected with
SARS-CoV or EAV [25,26]. In these RTC assays [a-32P]CMP is
incorporated into both genomic (replication) and sg mRNA
(transcription) (Fig. 2). This allowed us to monitor the synthesis of
the same viral RNA molecules that can be detected by
hybridization of RNA from nidovirus-infected cells. A benefit of
these assays is that the activity does not depend on continued
protein synthesis and that it allows us to study viral RNA synthesis
Author Summary
Positive-stranded RNA (+RNA) viruses include many
important pathogens. They have evolved a variety of
replication strategies, but are unified in the fact that an
RNA-dependent RNA polymerase (RdRp) functions as the
core enzyme of their RNA-synthesizing machinery. The
RdRp is commonly embedded in a membrane-associated
replication complex that is assembled from viral RNA, and
viral and host proteins. Given their crucial function in the
viral replicative cycle, RdRps are key targets for antiviral
research. Increased intracellular Zn2+ concentrations are
known to efficiently impair replication of a number of RNA
viruses, e.g. by interfering with correct proteolytic pro-
cessing of viral polyproteins. Here, we not only show that
corona- and arterivirus replication can be inhibited by
increased Zn2+ levels, but also use both isolated replication
complexes and purified recombinant RdRps to demon-
strate that this effect may be based on direct inhibition of
nidovirus RdRps. The combination of protocols described
here will be valuable for future studies into the function of
nidoviral enzyme complexes.
Zn2+ Inhibits Nidovirus Replication
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independent of other aspects of the viral replicative cycle [26]. To
investigate whether the inhibitory effect of PT and zinc ions on
nidovirus replication in cell culture is reflected in a direct effect of
Zn2+ on viral RNA synthesis, we tested the effect of Zn2+ addition
on RTC activity. For both EAV (Fig. 2A) and SARS-CoV
(Fig. 2B), a dose-dependent decrease in the amount of RNA
synthesized was observed when ZnOAc2 was present. For both
viruses, a more than 50% reduction of overall RNA-synthesis was
observed at a Zn2+ concentration of 50 mM, while less than 5%
activity remained at a Zn2+ concentration of 500 mM. Both
genome synthesis and sg mRNA production were equally affected.
To test whether the inhibition of RTC activity by Zn2+ was
reversible, RTC reactions were started in the presence or absence
of 500 mM Zn2+. After 30 min, these reactions were split into two
aliquots and magnesium-saturated EDTA (MgEDTA) was added
to one of the tubes to a final concentration of 1 mM (Fig. 3A). We
used MgEDTA as Zn2+ chelator in these in vitro assays, because it
specifically chelates Zn2+ while releasing Mg2+, due to the higher
stability constant of the ZnEDTA complex. Uncomplexed EDTA
inhibited RTC activity in all reactions (data not shown), most
likely by chelating the Mg2+ that is crucial for RdRp activity
[27,28], whereas MgEDTA had no effects on control reactions
without Zn2+ (Fig. 3B, compare lane 1 and 2). As shown in Fig. 2,
the EAV RTC activity that was inhibited by Zn2+ (Fig. 3B&C,
lane 3) could be restored by the addition of MgEDTA (Fig. 3B,
lane 4) to a level observed for control reactions without Zn2+
(Fig. 3B, lane 1). Compared to the untreated control, the EAV
RTC assay produced approximately 30% less RNA, which was
consistent with the 30% shorter reaction time after the addition of
the MgEDTA (100 versus 70 min for lanes 1 and 4, respectively).
Surprisingly, SARS-CoV RTC assays that were consecutively
supplemented with Zn2+ and MgEDTA incorporated slightly
more [a-32P]CMP compared to untreated control reactions
(Fig. 3C; compare lane 1 and 4). This effect was not due to
chelation of the Zn2+ already present in the post-nuclear
supernatant (PNS) of SARS-CoV-infected cells, as this increase
was not observed when MgEDTA was added to a control reaction
without additional Zn2+ (Fig. 3C, lane 2).
Figure 1. The zinc ionophore pyrithione inhibits nidovirus
replication in cell culture. (A) Cytotoxicity of PT in Vero-E6 cells in
the absence (blue circles) or presence of 2 (black squares), 4 (red
triangles), or 8 mM (gray diamonds) ZnOAc2 as determined by the MTS
assay after 18 hours of exposure. (B) Dose-response curves showing the
effect of PT and Zn2+ on the GFP fluorescence in Vero-E6 cells infected
with a GFP-expressing EAV reporter strain at 17 h p.i. Data were
normalized to GFP expression in infected, untreated control cultures
(100%). The different Zn2+ concentrations added to the medium were 0
(blue circles), 1 (green triangles), or 2 mM ZnOAc2 (black squares).
(C) Effect of PT and Zn2+ on the GFP fluorescence in Vero-E6 cells
infected with a GFP-expressing SARS-CoV reporter strain at 17 h p.i.
Data were normalized to GFP expression in infected untreated control
cells (100%). Colors for different Zn2+ concentrations as in Fig. 1B. Error
bars indicate the standard deviation (n = 4).
doi:10.1371/journal.ppat.1001176.g001
Figure 2. Inhibition of the in vitro RNA-synthesizing activity of
isolated RTCs by Zn2+. Incorporation of [a-32P]CMP into viral RNA by
EAV (A) and SARS-CoV (B) in RTC assays in the presence of various Zn2+
concentrations, as indicated above each lane.
doi:10.1371/journal.ppat.1001176.g002
Zn2+ Inhibits Nidovirus Replication
PLoS Pathogens | www.plospathogens.org 3 November 2010 | Volume 6 | Issue 11 | e1001176
Zinc ions affect the in vitro activity of recombinant
nidovirus RdRps
To establish whether inhibition of RTC activity might be due to
a direct effect of Zn2+ on nidovirus RdRp activity, we tested the
effect of Zn2+ on the activity of the purified recombinant RdRps of
SARS-CoV (nsp12) and EAV (nsp9) using previously developed
RdRp assays [27,28]. Using an 18-mer polyU template, the EAV
RdRp incorporated [a-32P]AMP into RNA products of up to 18
nt in length (Fig. 4A). Initiation was de novo, which is in line with
previous observations and the presence of a conserved priming
loop in the nsp9 sequence [28]. Unlike the EAV RdRp nsp9, the in
vitro activity of the SARS-CoV RdRp nsp12 - which lacks a
priming loop - was shown to be strictly primer-dependent [27].
Thus, to study the RdRp activity of SARS-CoV nsp12, a primed
polyU template was used (Fig. 4B), thereby allowing us to sample
[a-32P]AMP incorporation as described previously [27]. As
specificity controls, we used the previously described SARS-CoV
nsp12 mutant D618A [27], which contains an aspartate to alanine
substitution in motif A of the RdRp active site, and EAV nsp9-
D445A, in which we engineered an aspartate to alanine
substitution at the corresponding site of EAV nsp9 [28,31]. Both
mutant RdRps showed greatly reduced [a-32P]AMP incorporation
in our assays (Fig. 4), confirming once again that the radiolabeled
RNA products derived from nidovirus RdRp activity.
Addition of ZnOAc2 to RdRp assays resulted in a strong, dose-
dependent inhibition of enzymatic activity for both the EAV and
SARS-CoV enzyme (Fig. 5A and B, respectively), similar to what
was observed in RTC assays. In fact, compared to other divalent
metal ions such Co2+ and Ca2+, which typically bind to amino acid
side chains containing oxygen atoms rather than sulfur groups, Zn2+
was the most efficient inhibitor of SARS-CoV nsp12 RdRp activity
(Supplemental Fig. S1). To test whether, as in the RTC assay, the
RdRp inhibition by zinc ions was reversible, RdRp assays were pre-
incubated with 6 mM Zn2+, a concentration that consistently gave
.95% inhibition. After 30 min, 8 mM MgEDTA was added to
both a control reaction and the reaction inhibited with ZnOAc2,
and samples were incubated for another 30 min (Fig. 5C). As shown
in Fig. 5D, the inhibition of EAV RdRp activity by Zn2+ could be
reversed by chelation of Zn2+ (Fig. 5D; compare lanes 3 and 4). The
amount of product synthesized was consistently 6065% of that
synthesized in a 60-min control reaction (Fig. 5D; compare lanes 1
and 4), which was within the expected range given the shorter
Figure 3. Inhibition of nidovirus RTC activity by Zn2+ can be
reversed by chelation. (A) Schematic representation of the in vitro
assays with isolated RTCs, which were initiated with [a-32P]CTP, either in
the absence (sample 1 and 2) or presence of 500 mM Zn2+. After a 30-
min incubation at 30uC, both the untreated and Zn2+-treated samples
were split into two aliquots, and 1 mM of the Zn2+ chelator MgEDTA
was added to samples 2 and 4. All reactions were subsequently
incubated for another 70 min before termination. (B) Analysis of RNA
products synthesized in assays with EAV RTCs. Numbers above the
lanes refer to the sample numbers described under (A). (C) In vitro
activity assay with SARS-CoV RTCs.
doi:10.1371/journal.ppat.1001176.g003
Figure 4. EAV and SARS-CoV RdRp assays with wild-type
enzyme and active-site mutants. (A) The EAV polymerase was
incapable of primer extension and required a free 39 end and poly(U)
residues to initiate. Nucleotide incorporating activity of the wild-type
enzyme and D445A mutant of nsp9 on an 18-mer poly(U) template
confirmed the specificity of our assay. (B) SARS-CoV nsp12 RdRp assays
were performed with an RNA duplex with a 59 U10 overhang as
template. The bar graph shows the nucleotide incorporating activities
of wild-type and D618A nsp12. Error bars represent standard error of
the mean (n = 3).
doi:10.1371/journal.ppat.1001176.g004
Zn2+ Inhibits Nidovirus Replication
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reaction time. The inhibition of the SARS-CoV RdRp was
reversible as well. During the 30-min incubation after the addition
of MgEDTA, SARS-CoV nsp12 incorporated 4065% of the label
incorporated during a standard 60-min reaction (Fig. 5E). This was
slightly lower than the expected yield and may be caused by the
elevatedMg2+ concentration, which was shown to be suboptimal for
nsp12 activity [27] and results from the release of Mg2+ from
MgEDTA upon chelation of Zn2+.
Differential effect of Zn2+ on the initiation and elongation
phase of nidovirus RNA synthesis
For EAV, close inspection of the RdRp assays revealed a less
pronounced effect of Zn2+ on the generation of full-length 18-nt
products than on the synthesis of smaller reaction intermediates
(Fig. 5A). This suggested that Zn2+ specifically inhibited the
initiation step of EAV RNA synthesis. To test this hypothesis, an
RTC assay was incubated for 30 min with unlabeled CTP
(initiation), after which the reaction was split in two. Then,
[a-32P]CTP was added to both tubes (pulse), 500 mM Zn2+ was
added to one of the tubes, and samples were taken at different time
points during the reaction (Fig. 6A). Fig. 6B shows that in the
presence of Zn2+ [a-32P]CMP was predominantly incorporated
into nascent RNA molecules that were already past the initiation
phase at the moment that Zn2+ was added to the reaction. No new
initiation occurred, as was indicated by the smear of short
radiolabeled products that progressively shifted up towards the
position of full-length genomic RNA. This suggested that Zn2+
does not affect the elongation phase of EAV RNA synthesis and
that it specifically inhibits initiation. This also explains the
relatively weak signal intensity of the smaller sg mRNA bands
(e.g., compare the relative change in signal of RNA2 to RNA7)
produced in the presence of Zn2+, since multiple initiation events
are required on these short molecules to obtain signal intensities
similar to those resulting from a single initiation event on the long
genomic RNA, e.g., 16 times more in the case of RNA7. In
contrast to EAV, the effect of Zn2+ on RNA synthesis by SARS-
CoV RTCs was not limited to initiation, but appeared to impair
the elongation phase as well, given that the addition of Zn2+
completely blocked further incorporation of [a-32P]CMP when
added 40 min after the start of the reaction (Fig. 6C).
In the RdRp assays, the short templates used made it technically
impossible to do experiments similar to those performed with
complete RTCs. However, we previously noticed that at low
concentrations of [a-32P]ATP (,0.17 mM) SARS-CoV nsp12
RdRp activity was restricted to the addition of only a single
nucleotide to the primer [27]. EAV nsp9 mainly produced very
short (2–3 nt long) abortive RNA products and only a fraction of
full length products, as is common for de novo initiating RdRps
[28]. This allowed us to separately study the effect of Zn2+ on
initiation and elongation by performing an experiment in which a
pulse with a low concentration of [a-32P]ATP was followed by a
chase in the presence of 50 mM of unlabeled ATP, which
increased processivity and allowed us to study elongation (Fig. 7A
and C) as described previously [27]. The results of these
experiments were in agreement with those obtained with isolated
RTCs. For EAV, with initiation and dinucleotide synthesis
completely inhibited by the presence of 6 mM Zn2+ (Supplemental
Fig. S2A), the amount of reaction intermediates shorter than 18 nt
diminished with time, while products from templates on which the
RdRp had already initiated were elongated to full-length 18-nt
molecules (Fig. 7B, right panel). This was consistent with the
observation that the EAV RdRp remained capable of extending
the synthetic dinucleotide ApA to trinucleotides in the presence of
Zn2+ (Supplemental Fig. S2B). Likely due to the absence of
reinitiation in the reactions shown in Fig. 7B, the low processivity
of the EAV RdRp, and the substrate competition between the
remaining [a-32P]ATP and the .200 fold excess of unlabeled
ATP, the differences between the 5- and 30-min time points were
small. In the absence of Zn2+, the RdRp continued to initiate as
indicated by the ladder of smaller-sized RNA molecules below the
full-length product (Fig. 7B, left panel) and the time course shown
in Supplemental Fig. S2A. In contrast, the addition of Zn2+ to a
SARS-CoV RdRp reaction also blocked elongation, since
Figure 5. The activity of the RdRps of EAV and SARS-CoV is
reversibly inhibited by Zn2+. RdRp activity of purified EAV nsp9 (A)
and SARS-CoV nsp12 (B) in the presence of various Zn2+ concentrations,
as indicated above the lanes. (C) Schematic representation of the
experiment to test whether Zn2+-mediated inhibition of RdRp activity
could be reversedwithMgEDTA. RdRp reactions, either untreated controls
(sample 1 and 2) or reactions containing 6 mM Zn2+ (samples 3 and 4)
were incubated for 30 min. Both Zn2+-containing and control samples
were split into two aliquots and 6 mM MgEDTA was added to sample 2
and 4. All reactions were incubated for an additional 30 min and then
terminated. Reaction products of the RdRp assays with EAV nsp9 and
SARS-CoV nsp12 are shown in (D) and (E), respectively. Numbers above
the lanes refer to the sample numbers described under (C).
doi:10.1371/journal.ppat.1001176.g005
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extension of the radiolabeled primer as observed in the absence of
Zn2+ (Fig. 7D, left panel) no longer occurred (Fig. 7D, right panel).
Zinc affects SARS-CoV RdRp template binding
To assess whether Zn2+ affects the interaction of recombinant
SARS-CoV nsp12 with the template used in our assays, we
performed electromobility shift assays (EMSA) in the presence and
absence of Zn2+ (Fig. 8A). To measure the binding affinity of the
RdRp for the template, we determined the fraction of bound
template at various protein concentrations and observed a 3–4 fold
reduction in RNA binding when Zn2+ was present in the assay
(Fig. 8B). We also assessed whether pre-incubation of the RdRp or
RNA with Zn2+ was a requirement for this drop in binding
affinity, but found no significant difference with experiments not
involving such a preincubation (data not shown).
No binding was observed when a similar RNA binding assay
was performed with purified EAV RdRp. Likewise, nsp9 did not
bind RNA in pull-down experiments with Talon-beads, His6-
tagged nsp9, and radiolabeled EAV genomic RNA or various
short RNA templates including polyU, whereas we were able to
detect binding of a control protein (SARS-CoV nsp8, which has
demonstrated RNA and DNA binding activity [32]) using this
assay. It presently remains unclear why we are not able to detect
the binding of recombinant EAV nsp9 to an RNA template.
Discussion
Although a variety of compounds have been studied, registered
antivirals are currently still lacking for the effective treatment of
SARS and other nidovirus-related diseases [33]. RdRps are
suitable targets for antiviral drug development as their activity is
strictly virus-specific and may be blocked without severely affecting
key cellular functions. Several inhibitors developed against the
polymerases of e.g. human immunodeficiency virus (HIV) and
hepatitis C virus are currently being used in antiviral therapy or
clinical trials [34,35,36]. Therefore, advancing our molecular
knowledge of nidovirus RdRps and the larger enzyme complexes
that they are part of, and utilizing the potential of recently
developed in vitro RdRp assays [25,26,27,28] could ultimately aid
in the development of effective antiviral strategies.
Zinc ions and zinc-ionophores, such as PT and PDTC, have
previously been described as potent inhibitors of various RNA
viruses. We therefore investigated whether PT-stimulated import
of zinc ions into cells also inhibited the replication of nidoviruses in
cell culture. Using GFP-expressing EAV and SARS-CoV [29,30],
we found that the combination of 2 mM PT and 2 mM Zn2+
efficiently inhibited their replication, while not causing detectable
cytoxicity (Fig. 1). Inhibition of replication by PT and Zn2+ at
similar concentrations (2–10 mM) was previously observed for
several picornaviruses such as rhinoviruses, foot-and-mouth
disease virus, coxsackievirus, and mengovirus [6,7,8,9,10,11].
The inhibitory effect of Zn2+ on the replication of picornaviruses
appeared to be due to interference with viral polyprotein processing.
In infections with the coronavirus mouse hepatitis virus (MHV),
Zn2+ also interfered with some of the replicase polyproteins
cleavages [24], albeit at a much higher concentration (100 mM
Zn2+) than used in our studies. Since impaired replicase processing
will indirectly affect viral RNA synthesis in the infected cell, we used
two recently developed in vitro assays to investigate whether Zn2+
also affects nidovirus RNA synthesis directly. Our in vitro studies
revealed a strong inhibitory effect of zinc ions on the RNA-
synthesizing activity of isolated EAV and SARS-CoV RTCs. Assays
with recombinant enzymes subsequently demonstrated that this was
likely due to direct inhibition of RdRp function. The inhibitory
effect could be reversed by chelating the zinc ions, which provides
an interesting experimental (on/off) approach to study nidovirus
RNA synthesis. Addition of Zn2+ following initiation of EAV RNA
synthesis had little or no effect on NTP incorporation in molecules
whose synthesis had already been initiated in the absence of Zn2+
(Fig. 6 and 7), indicating that Zn2+ does not affect elongation and
does not increase the termination frequency, as was previously
found for Mn2+ [25]. Therefore, Zn2+ appears to be a specific
inhibitor of the initiation phase of EAV RNA synthesis. In contrast,
Zn2+ inhibited SARS-CoV RdRp activity also during the
elongation phase of RNA synthesis, probably by directly affecting
template binding (Fig. 8). In coronaviruses, zinc ions thus appear to
inhibit both the proper proteolytic processing of replicase
polyproteins [23,24] and RdRp activity (this study). Contrary to
the RTC assays, millimolar instead of micromolar concentrations of
ZnOAc2 were required for a nearly complete inhibition of
nucleotide incorporation in RdRp assays.
It has been well established that DNA and RNA polymerases use a
triad of conserved aspartate residues in motifs A and C to bind
Figure 6. Effect of Zn2+ on initiation and elongation in in vitro
assays with isolated EAV and SARS-CoV RTCs. (A) An in vitro RTC
assay with isolated EAV RTCs was allowed to initiate with unlabeled
NTPs (initiation). After 30 min, [a-32P]CTP was added (pulse), the
reaction was split into two equal volumes, and Zn2+ was added to a
final concentration of 0.5 mM to one of the tubes. At the time points
indicated, samples were taken and incorporation of [a-32P]CMP into
viral RNA was analyzed. (B) Radiolabeled EAV RNA synthesized at the
time points indicated above the lanes in the presence and absence of
Zn2+. (C) Radiolabeled RNA synthesized by isolated SARS-CoV RTCs in
reactions terminated after 100 (lane 1) and 40 (lane 2) min. Reaction
products of a reaction to which 500 mM Zn2+ was added after 40 min,
and that was terminated at t = 100 are shown in lane 3.
doi:10.1371/journal.ppat.1001176.g006
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divalent metal ions like Mg2+, which subsequently coordinate
incoming nucleotides during the polymerization reaction [37,38].
Mg2+ is also the divalent metal ion that is required for the in vitro
activity of isolated SARS-CoV and EAV RTCs and recombinant
RdRps [25,26,27,28], although de novo initiation of EAV nsp9 is
primarily Mn2+-dependent. Zn2+ could not substitute for Mg2+ or
Mn2+ as cofactor as it was incapable of supporting the polymerase
activity of nidovirus RTCs and RdRps in the absence of Mg2+ (data
not shown), as was also reported for the poliovirus RdRp [39].
Moreover, inhibition of nidovirus RdRp activity by Zn2+ was even
observed at low concentrations and in the presence of a more than
25-fold excess of Mg2+, suggesting that either the affinity of the active
site for Zn2+ is much higher or that Zn2+ does not compete for Mg2+-
binding and binds to another zinc(-specific) binding site in the protein.
Specific protein domains or pockets that contain zinc ions may
be involved in protein-protein interactions, protein-RNA/DNA
interactions, or conformational changes in enzyme structures.
Zinc-binding domains commonly consist of at least three
conserved cysteine and/or histidine residues within a stretch of
,10–30 amino acids, such as in zinc-finger motifs and
metalloproteases [2,40,41]. However, in RdRps there are only
few precedents for the presence of zinc-binding pockets, such as
those identified in the crystal structure of the Dengue RdRp [42].
Sequence analysis of the EAV nsp9 amino acid sequence revealed
that it lacks patches rich in conserved cysteines and/or histidines.
In contrast, inspection of the SARS-CoV nsp12 amino acid
sequence revealed two such patches, namely H295-C301-C306-
H309-C310 and C799-H810-C813-H816. A crystal structure for
nsp12 is presently unavailable, but a predicted structure that
represents the C-terminal two-thirds of the enzyme has been
published [31]. Interestingly, in this model, C799, H810, C813
and H816 are in a spatial arrangement resembling that of the Zn2+
Figure 7. The effect of Zn2+ on initiation and elongation activity of purified EAV and SARS-CoV RdRps. (A) An EAV RdRp reaction was
initiated in the presence of [a-32P]ATP under conditions that do not allow elongation, i.e., low ATP concentration. After 20 min, the reaction was split
into two equal volumes, and Zn2+ was added to one of the tubes. A chase with 50 mM unlabeled ATP, which allows elongation, was performed on
both reactions and samples were taken after 5 and 30 min. (B) EAV RdRp reaction products that accumulated in the presence and absence of Zn2+
(indicated above the lanes) after a 5- and 30-min chase with unlabeled ATP. The length of the reaction products in nt is indicated next to the gel.
(C) A SARS-CoV RdRp reaction was initiated in the presence of 0.17 mM [a-32P]ATP, which limits elongation. After 10 min, the reaction was split into
two equal volumes, and Zn2+ was added to one of the tubes. A chase with 50 mM unlabeled ATP was performed on both reactions and samples were
taken after 5, 10, 15, and 30 min. (D) SARS-CoV RdRp reaction products formed at the chase times indicated above the lanes in the presence and
absence of Zn2+. The length of the reaction products in nt is indicated next to the gel (p is the primer length).
doi:10.1371/journal.ppat.1001176.g007
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coordinating residues in the Zn2 zinc-binding pocket found in
motif E of the Dengue virus RdRp (see Supplemental Fig. S3).
Clearly, an in-depth analysis of nidovirus RdRps, e.g. through
structural analysis and subsequent mutational studies targeting
aforementioned cysteines and histidines, is required to provide
further insight into and a structural basis for the Zn2+-induced
inhibitory effects on RdRp activity documented in this study. Such
studies may, however, be complicated when Zn2+ binding proves
to be very transient in nature and not detectable with currently
available methods.
In summary, the combination of zinc ions and the zinc-ionophore
PT efficiently inhibits nidovirus replication in cell culture. This
provides an interesting basis for further studies into the use of zinc-
ionophores as antiviral compounds, although systemic effects have
to be considered [43,44] and a water-soluble zinc-ionophore may be
better suited, given the apparent lack of systemic toxicity of such a
compound at concentrations that were effective against tumors in a
mouse xenograft model [45]. In vitro, the reversible inhibition of the
RdRp by Zn2+ has also provided us with a convenient research tool
to gain more insight into the molecular details of (nido)viral RNA
synthesis, and revealed novel mechanistic differences between the
RdRps of SARS-CoV and EAV.
Materials and Methods
Cells and viruses
Vero-E6 cells were cultured and infected with SARS-CoV
(strain Frankfurt-1; accession nr. AY291315) or SARS-CoV-GFP
as described previously [46]. All procedures involving live SARS-
CoV were performed in the biosafety level 3 facility at Leiden
University Medical Center. BHK-21 or Vero-E6 cells were
cultured and infected with EAV (Bucyrus strain; accession nr.
NC_002532) or EAV-GFP [29] as described elsewhere [25].
Effect of zinc ions on nidovirus replication in cell culture
One day prior to infection, Vero-E6 cells were seeded in
transparent or black (low fluorescence) 96-well clusters at 10,000
cells per well. The next day, cells were infected with SARS-CoV-GFP
or EAV-GFP with an m.o.i. of 4, and 1 h p.i. the inoculum was
removed and 100 ml of medium containing 2% fetal calf serum (FCS)
was added to each well. In some experiments 0–32 mM of pyrithione
(Sigma) was added in addition to 0–2 mM ZnOAc2. Infected cells
were fixed at 17 h p.i. by aspirating the medium and adding 3%
paraformaldehyde in PBS. After washing with PBS, GFP expression
was quantified by measuring fluorescence with a LB940Mithras plate
reader (Berthold) at 485 nm. To determine toxicity of ZnOAc2 and
PT, cells were exposed to 0–32 mM PT and 0–8 mM ZnOAc2. After
18 h incubation, cell viability was determined with the Cell Titer 96
AQ MTS assay (Promega). EC50 and CC50 values were calculated
with Graphpad Prism 5 using the nonlinear regression model.
RNA templates and oligonucleotides
RNA oligonucleotides SAV557R (59-GCUAUGUGAGAU-
UAAGUUAU-39), SAV481R (59-UUUUUUUUUUAUAACUU-
AAUCUCACAUAGC-39) and poly(U)18 (59-UUUUUUUUU-
UUUUUUUUU-39) were purchased from Eurogentec, purified
from 7 M Urea/15% PAGE gels and desalted through NAP-10
columns (GE healthcare). To anneal the RNA duplex SAV557R/
SAV481R, oligonucleotides were mixed at equimolar ratios in
annealing buffer (20 mM Tris-HCl pH 8.0, 50 mM NaCl and
5 mM EDTA), denatured by heating to 90uC and allowed to
slowly cool to room temperature after which they were purified
from 15% non-denaturing PAGE gels.
In vitro viral RNA synthesis assay with isolated RTCs
SARS-CoV and EAVRTCs were isolated from infected cells and
assayed for activity in vitro as described previously [25,26]. To assess
the effect of Zn2+, 1 ml of a ZnOAc2 stock solution was added to
standard 28-ml reactions, resulting in final Zn2+ concentrations of
10–500 mM. When Zn2+ had to be chelated in the course of the
reaction, magnesium-saturated EDTA (MgEDTA) was added to a
final concentration of 1 mM. After RNA isolation, the 32P-labeled
reaction products were separated on denaturing 1% (SARS-CoV)
or 1.5% (EAV) agarose formaldehyde gels. The incorporation of
[a-32P]CMP into viral RNA was quantified by phosphorimaging of
the dried gels using a Typhoon scanner (GE Healthcare) and the
ImageQuant TL 7 software (GE Healthcare).
Expression and purification of nidovirus RdRps
SARS-CoV nsp12 and EAV nsp9 were purified essentially as
described elsewhere [27,28], but with modifications for nsp9. In
short, E. coli BL21(DE3) with plasmid pDEST14-nsp9-CH was
grown in auto-induction medium ZYM-5052 [47] for 6 hours at
37uC and a further 16 hours at 20uC. After lysis in buffer A
(20 mM HEPES pH 7.4, 200 mM NaCl, 20 mM imidazole, and
0.05% Tween-20) the supernatant was applied to a HisTrap
column (GE Healthcare). Elution was performed with a gradient
of 20–250 mM imidazole in buffer A. The nsp9-containing
fraction was further purified by gel filtration in 20 mM HEPES,
300 mM NaCl and 0.1% Tween-20 on a Superdex 200 column
(GE Healthcare). The fractions containing nsp9-CH were pooled,
dialyzed against 1000 volumes of buffer B (20 mM HEPES,
100 mM NaCl, 1 mM DTT and 50% glycerol) and stored at
220uC. RdRps with a D618A (SARS-CoV) or D445A (EAV)
mutation were obtained by site-directed mutagenesis of the wild-
type (wt) plasmid pDEST14-nsp9-CH [28] with oligonucleotides
59-TACTGCCTTGAAACAGCCCTGGAGAGTTGTGAT-39
and 59-ATCACAACTCTCCAGGGCTGTTTCAAGGCAGTA
-39, and plasmid pASK3-Ub-nsp12-CHis6 with oligonucleotides
59-CCTTATGGGTTGGGCTTATCCAAAATGTG-39 and 59-
CACATTTTGGATAAGCCCAACCCATAAGGA-39, as de-
scribed elsewhere [27]. Mutant proteins were purified parallel to
the wt enzymes.
Figure 8. The effect of Zn2+ on SARS-CoV nsp12 template
binding. (A) Electrophoretic mobility shift assay with radiolabeled
dsRNA and nsp12 in the presence and absence of Zn2+ (indicated above
the lanes). The position of unbound and nsp12-bound RNA in the gel is
marked on the left of the panel. (B) Determination of the nsp12 affinity
for RNA in the presence and absence of Zn2+. A fixed amount of RNA
was incubated with an increasing amount of nsp12. This revealed a 3–4
fold reduction in the percentage of bound RNA in the presence of zinc
ions (grey) relative to the percentage of bound RNA in the absence of
zinc ions (black). Error bars represent standard error of the mean (n = 3).
doi:10.1371/journal.ppat.1001176.g008
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RdRp assays with purified enzymes
Standard reaction conditions for the RdRp assay with 0.1 mM of
purified SARS-CoV nsp12 are described elsewhere [27]. To study
the effect of Zn2+ in this assay, 0.5 ml of a dilution series of
0–80 mMZnOAc2 was added to the 5 ml reaction mixture, yielding
final Zn2+ concentrations of 0–8 mM. The EAV RdRp assay
contained 1 mM nsp9, 1 mM RNA template poly(U)18, 0.17 mM
[a-32P]ATP (0.5 mCi/ml; Perkin-Elmer), 50 mMATP, 20 mMTris-
HCl (pH 8.0), 10 mM NaCl, 10 mM KCl, 1 mM MnCl2, 4 mM
MgOAc2, 5% glycerol, 0.1% Triton-X100, 1 mM DTT and 0.5
units RNaseOUT. ZnOAc2 was added to the reaction to give a final
concentration of 0–6 mM. To chelate Zn2+ during reactions,
MgEDTA was added to a final concentration of 8 mM. Reactions
were terminated after 1 hour and analyzed as described [27].
SARS-CoV nsp12 electrophoretic mobility shift assay
SARS-CoV RdRp was incubated with 0.2 nM 59 32P-labeled
SAV557R/SAV481R RNA duplex, for 10 minutes at 30uC either
in presence or absence of 6 mM ZnOAc2. Reactions were
analyzed as described previously [27].
Supporting Information
Figure S1 Effect of various divalent cations on the RdRp
activity of SARS-CoV nsp12. Purified recombinant SARS-
CoV nsp12 was incubated with a primed template, ATP, and
[a-32P]ATP in the presence of either 6 mM Mg2+ only (lane 1),
and with increasing concentrations of a second divalent metal
(M2+), specifically: 2–6 mM Ca2+ (lane 2–4), 2–6 mM Co2+ (lane
5–7), 2–6 mM Zn2+ (lane 8–10), or 2–6 mM Mn2+ (lane 11–13).
The strongest inhibition was observed for Zn2+. For more details
on the SARS-CoV nsp12 RdRp assay, see the main text.
Found at: doi:10.1371/journal.ppat.1001176.s001 (1.55 MB TIF)
Figure S2 Effect of Zn2+ on the dinucleotide extension
activity of EAV nsp9. Purified recombinant EAV nsp9 was
incubated with a U18 template in the presence of [a-32P]ATP,
ATP, 4 mM Mg2+, 1 mM Mn2+, and 1 mM ApA. (A) Reaction
mixtures were split into two aliquots, one of which was
supplemented with 6 mM Zn2+, and samples were taken at the
time points (minutes) indicated above the lanes. In the absence of
Zn2+, EAV nsp9 initiates de novo and produces di- and
trinucleotides, indicated with A2 and A3, respectively. A non-
specific band, unrelated to RdRp activity, between A2 and A3 is
indicated with an asterisk. In the presence of 6 mM Zn2+, the
synthesis of dinucleotides and trinucleotides was blocked. (B) When
performing the assay described under (A) in the absence of Zn2+, a
full-length product of 18 nucleotides is formed. This product is not
observed when the assay is performed in the presence of 6 mM
Zn2+, but nsp9 was capable of elongating the provided dinucleotide
primer ApA into tri- (ApA*pA) and tetranucleotide ((ApA*pA*pA)
products (the asterisk indicates radiolabeled phosphates). Due to the
absence of a 59 triphosphate group, these reaction products migrate
much slower in the 20% acrylamide and 7 M urea gel used for this
analysis. See the main text for additional experimental details on the
EAV nsp9 RdRp assay.
Found at: doi:10.1371/journal.ppat.1001176.s002 (2.16 MB TIF)
Figure S3 Putative zinc-binding residues in the predict-
ed structure of SARS-CoV nsp12 and comparison with
the structure of the zinc-containing Dengue virus RdRp
domain. (A) Sequence alignment of coronavirus RdRps showing
conservation of four potential zinc-binding residues amino acids
(C799-H810-C813-H816 in SARS-CoV; indicated with asterisks)
in the C-terminal region of coronavirus nsp12. Black shading
indicates complete conservation among coronaviruses. The
coronavirus RdRp sequences were aligned with Muscle 3.6. The
aligned sequences and NCBI accession numbers are the following:
mouse hepatitis virus strain A59 (MHV_A59; NP_068668),
human CoV 229E (HCoV_229E; NP_068668), infectious bron-
chitis virus strain Beaudette (IBV_B; P0C6Y1), bovine coronavirus
(BCoV; NP_742138.1), feline coronavirus (FeCoV; YP_239353.1),
and SARS-CoV strain Frankfurt-1 (SARS_Fr1; AAP33696).
(B) Crystal structure of the Dengue virus RdRp domain showing
the position of four cysteine and histidine residues that form Zn2+
-binding pocket Zn2, located close to motif E (depicted in red). A
second Zn2+-binding pocket (Zn1) and the two zinc ions identified
in the crystal structure are indicated in blue-gray. (C) Predicted
three-dimensional structure model of SARS-CoV nsp12 (Xu et al.,
Nucl. Acids Res. 31: 7117–7130), based on PDB code 1O5S,
rendered with Swiss-PdbViewer 4.01 and POV-Ray 3.6. The
positions of the conserved cysteine and histidine residues indicated
in panel A (C799-H810-C813-H816) close to motif E (depicted in
red) and RdRp active-site residues (D618, D760 and D761) are
indicated. The spatial arrangement of these cysteines and
histidines in this model strikingly resembles the positioning of
the metal ion-coordinating residues of Zn-binding pocket Zn2 in
the Dengue virus RdRp domain (see panel B).
Found at: doi:10.1371/journal.ppat.1001176.s003 (0.86 MB TIF)
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